Compounds > cabergoline
Page last updated: 2024-08-23

cabergoline and Hypomenorrhea

cabergoline has been researched along with Hypomenorrhea in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bianchi, A; Carrozza, C; D'Ercole, M; Della Pepa, GM; Doglietto, F1
Colao, A; Di Somma, C; Lombardi, G; Pivonello, R; Savastano, S; Tauchmanovà, L1
Abs, R; Bevan, JS; Brabant, G; Ciccarelli, E; Ferrari, CI; Motta, T; Mucci, M; Muratori, M; Musatti, L; Scanlon, MF; Verbessem, G1
Atkinson, AB; Bell, PM; Courtney, CH; Ellis, PK; Hadden, DR; Leslie, H; McCance, DR; Sheridan, B1
Crosignani, P; D'Alberton, A; de Vincentiis, S; Ferrari, C; Mattei, AM; Paracchi, A1

Other Studies

5 other study(ies) available for cabergoline and Hypomenorrhea

ArticleYear
Two diagnostic pitfalls mimicking a prolactin-secreting microadenoma.
    The Journal of clinical endocrinology and metabolism, 2010, Volume: 95, Issue:12

    Topics: Adenoma; Adult; Antineoplastic Agents; Cabergoline; Diagnosis, Differential; Diagnostic Errors; Ergolines; Female; Galactorrhea; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Menstruation Disturbances; Pituitary Neoplasms; Prolactin

2010
Growth hormone excess with onset in adolescence: clinical appearance and long-term treatment outcome.
    Clinical endocrinology, 2007, Volume: 66, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Agents, Hormonal; Body Height; Body Mass Index; Bromocriptine; Cabergoline; Combined Modality Therapy; Ergolines; Female; Growth Hormone; Growth Hormone-Secreting Pituitary Adenoma; Headache; Hormone Antagonists; Humans; Insulin Resistance; Insulin-Like Growth Factor I; Male; Menstruation Disturbances; Octreotide; Peptides, Cyclic; Pituitary Neoplasms; Retrospective Studies; Somatostatin; Treatment Outcome

2007
Treatment of macroprolactinoma with cabergoline: a study of 85 patients.
    Clinical endocrinology, 1997, Volume: 46, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Infertility, Male; Male; Menstruation Disturbances; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma

1997
Laboratory and clinical experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method.
    The Journal of clinical endocrinology and metabolism, 2001, Volume: 86, Issue:6

    Topics: Adult; Bromocriptine; Cabergoline; Cohort Studies; Ergolines; Female; Fertility; Headache; Humans; Magnetic Resonance Imaging; Medical Records; Menstruation; Menstruation Disturbances; Middle Aged; Pituitary Gland; Polyethylene Glycols; Prolactin; Tomography, X-Ray Computed

2001
Cabergoline in the long-term therapy of hyperprolactinemic disorders.
    Acta endocrinologica, 1992, Volume: 126, Issue:6

    Topics: Adolescent; Adult; Aged; Bromocriptine; Cabergoline; Drug Resistance; Ergolines; Female; Humans; Hyperprolactinemia; Male; Menstruation Disturbances; Middle Aged; Ovulation; Pituitary Neoplasms; Prolactinoma

1992